Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beam Therapeutics Inc. - Common Stock (NQ:BEAM)

31.27 -0.78 (-2.43%)
Streaming Delayed Price Updated: 1:57 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Beam Therapeutics Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Beam Therapeutics to Participate in Upcoming May Investor Conferences
From Beam Therapeutics
Via GlobeNewswire
News headline image
Cathie Wood Is Loading Up on These 3 Stocks Down 70% or More. Should You? ↗
The Ark Invest CEO is betting on rebounds for these beaten-down stocks. 
Via The Motley Fool
News headline image
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
From Beam Therapeutics
Via GlobeNewswire
News headline image
Beam Therapeutics: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Where Beam Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Where Beam Therapeutics Stands With Analysts ↗
 
Via Benzinga
News headline image
Analyst Ratings for Beam Therapeutics ↗
 
Via Benzinga
News headline image
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
From Beam Therapeutics
Via GlobeNewswire
News headline image
7 Best Cathie Wood Stocks for Your May 2023 Buy List ↗
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent. 
Via InvestorPlace
News headline image
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers ↗
Cathie Wood is loading up on these biotech stocks. 
Via The Motley Fool
News headline image
The 3 Most Promising Gene Editing Stocks to Buy in 2023 ↗
Intellia, Beam, and Editas are using gene editing to cure incurable diseases. These are three gene editing stocks you'll want to invest in. 
Via InvestorPlace
News headline image
Cathie Wood Is Unstoppable With Tesla Stock – Defies Wall Street To Make Whopping $29M Purchase ↗
 
Via Benzinga
News headline image
3 Stocks to Watch in April: Is it Time to Buy? ↗
With several fundamental factors pushing against the equities sector, these stocks to watch in particular draw significant intrigue. 
Via InvestorPlace
News headline image
7 Top Growth Stocks to Buy for the Next Decade ↗
These Growth Stocks to Buy Don't Require a 10-year Horizon But Should be More Valuable Then 
Via InvestorPlace
News headline image
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global ↗
 
Via Benzinga
News headline image
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures ↗
For those that can handle the heat, these biotech stocks to buy undergird some of the most powerful innovations in medicine. 
Via InvestorPlace
News headline image
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
From Beam Therapeutics
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗
 
Via Benzinga
News headline image
Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer
From Beam Therapeutics
Via GlobeNewswire
News headline image
Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference
From Beam Therapeutics
Via GlobeNewswire
News headline image
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing ↗
CRISPR Therapeutics, Beam Therapeutics and Vertex Pharmaceuticals are three CRISPR gene editing stocks you won't want to miss out on. 
Via InvestorPlace
News headline image
3 Game-Changing Stocks to Buy in March ↗
Innovation is in these companies' DNA. 
Via The Motley Fool
News headline image
The Top 7 Growth Stocks in Biotech ↗
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term. 
Via InvestorPlace
News headline image
Beam Therapeutics to Participate in the 43rd Annual Cowen Healthcare Conference
From Beam Therapeutics
Via GlobeNewswire
News headline image
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
From Beam Therapeutics
Via GlobeNewswire
News headline image
Better Buy: Beam Therapeutics or Intellia Therapeutics? ↗
The two clinical-stage gene-editing companies have good long-term prospects. 
Via The Motley Fool
News headline image
Beam Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
From Beam Therapeutics
Via GlobeNewswire
News headline image
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129% ↗
Cathie Wood is bullish about these stocks. And so are Wall Street analysts. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023 ↗
 
Via Benzinga
News headline image
7 CRISPR Stocks With the Best Long-Term Potential ↗
CRISPR stocks are becoming commercially viable leading to substantial returns in 2023 and beyond, as the technology will only improve. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.